# Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

> **NCT02653014** · PHASE1 · COMPLETED · sponsor: **KBP Biosciences** · enrollment: 26 (actual)

## Conditions studied

- Healthy
- Renal Insufficiency

## Interventions

- **DRUG:** KBP-5074

## Key facts

- **NCT ID:** NCT02653014
- **Lead sponsor:** KBP Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-29
- **Primary completion:** 2016-05-26
- **Final completion:** 2017-03-28
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02653014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02653014, "Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02653014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*